Daratumumab

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Daratumumab and local guidelines before prescribing.

Anti-CD38 monoclonal antibody

Mechanism

CD38 monoclonal antibody.

Uses

Multiple myeloma.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Infusion reactions, neutropenia, infection, interference with cross-matching.

Interactions

Interferes with blood group serology.

Contraindications and cautions

Hypersensitivity

Monitoring

FBC, blood group record

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

No adjustment

Overdose and reversal

Supportive

Special advice

Notify blood bank before transfusion; premedicate; hepatitis B screening.

More from the textbook: uses, cautions and other points
Where it is discussed in the book